社会护理工作人员的一般痴呆症培训:系统性审查
Clarissa Giebel1,2, Thais Caprioli1,2, Marie Poole3,4
1Department of Primary Care & Mental Health, University of Liverpool, Liverpool, UK.
Journal of advanced nursing
|October 21, 2025
概括
这一系统性审查发现,社会护理工作人员的痴呆症培训提高了员工的知识和信心. 在全球范围内实施这些已有证据的干预措施可以加强痴呆症护理,特别是在低收入国家.
科学领域:
- 老年学和社会护理研究研究
- 医疗保健 劳动力 教育 医疗保健 劳动力 教育
背景情况:
- 社会护理工作人员需要有效的痴呆症培训,以满足全球老龄化人口的需求.
- 现有的社会护理专业人员的一般性痴呆教育计划在内容和交付方面存在很大差异.
研究的目的:
- 系统地审查和综合全球关于为社会护理工作人员提供痴呆症培训的证据.
- 评估各种培训干预措施对员工知识,信心和护理服务的有效性.
主要方法:
- 进行了混合方法系统审查.
- 搜索包括五个主要的数据库 (PubMed,APA PsychINFO,CINAHL Plus,Scopus,Web of Science) 来搜索2010年至2024年7月的研究.
- 数据被提取并综合叙述,比较培训内容,交付方式,劳动力和结果.
主要成果:
- 包括来自13个国家的27项研究,主要关注养老院工作人员.
- 培训采用了面对面,远程和混合交付模式.
- 积极的影响在员工的知识和信心中最为明显;对痴呆症患者的影响的证据有限且混杂.
结论:
- 多种痴呆症培训计划,包括面对面和远程选择,积极影响社会护理工作人员的知识和护理服务.
- 在全球范围内实施经验证实的干预措施可以提高痴呆症知识,特别是在资源有限的环境中.
- 护士和其他社会护理工作人员从这种专业培训中获益很大.
更多相关视频
相关概念视频
Dementia
480
Dementia is a collective term for cognitive disorders primarily affecting memory, thinking, and reasoning. It is not a specific disease but a syndrome, with Alzheimer's disease being the most common cause, accounting for approximately 60-80% of cases. Other types include vascular dementia, Lewy body dementia, and frontotemporal dementia. Dementia affects millions worldwide, particularly older adults, though it is not a normal part of aging.
The progression of dementia is generally gradual....
The progression of dementia is generally gradual....
480
Alzheimer's Disease: Overview
1.5K
Alzheimer's Disease (AD) is a continually advancing neurodegenerative disorder, distinguished by escalating memory loss, cognitive dysfunction, and dementia. The disease unfolds in three stages: preclinical, mild cognitive impairment (MCI), and dementia. Its onset is insidious, and the progression gradual, with the cause not well explained by other disorders.
The clinical diagnosis of AD hinges on the presence of memory and other cognitive impairments. Biomarkers, such as changes in Aβ...
The clinical diagnosis of AD hinges on the presence of memory and other cognitive impairments. Biomarkers, such as changes in Aβ...
1.5K
Alzheimer's Disease: Treatment
736
Alzheimer's Disease (AD), a neurodegenerative disorder, is pathologically identified by amyloid plaques and neurofibrillary tangles composed of tau protein. AD pharmacotherapy aims to manage cognitive symptoms, delay disease progression, and treat behavioral symptoms. The treatment is primarily symptomatic and palliative, with no definitive disease-modifying therapy available. Cholinesterase inhibitors, including donepezil (Aricept), rivastigmine (Exelon), and galantamine (Razadyne), are...
736
Documentation in Long-Term and Home Healthcare Setting
1.4K
Documentation in long-term care facilities and home healthcare settings is crucial for ensuring continuous, coordinated, and comprehensive care for patients. Each setting has its specific documentation processes and tools:
Long-Term Care Facilities
Long-Term Care Facilities
1.4K
Cognitive Development During Adulthood
737
Cognitive development continues throughout adulthood, undergoing significant shifts across early, middle, and late stages. Individual transition occurs from adolescent idealism to pragmatic and adaptable thinking in early adulthood. During this period, individuals learn to integrate personal beliefs with the recognition that other perspectives are equally valid. Exposure to the complexities of modern society, diverse experiences, and higher education contribute to this adaptive thought process,...
737
Pharmacodynamics in Geriatric Patients: Effects of Age
172
Age-related pharmacokinetic changes are extensively documented, but understanding age-related pharmacodynamic alterations is relatively limited. This knowledge gap can be partly attributed to the complexity of developing appropriate measures of drug responses compared to bioanalytical methods for determining drug concentrations.Most information regarding age-related differences in human pharmacodynamics originates from cross-sectional studies. However, these studies assume that observed mean...
172


